In the IFX group, IFX was withdrawn in five patients (17%), including three females with infusion reaction, a male with seroconversion of the interferon-gamma release assay (a marker for tuberculosis), and another male with pneumocystis pneumonia. On the other hand, ADA was withdrawn in one...
Genetic testing in SRNS patients (i) may provide patients and families with an unequivocal diagnosis, (ii) may uncover a form of SRNS that is amenable to treatment (e.g., coenzyme Q10), (iii) may avoid the necessity of a renal biopsy and allow early weaning of immunosuppressive therapy, ...